Clinical benefit of graduated compression stockings for prevention of venous thromboembolism after total knee arthroplasty: post hoc analysis of a phase 3 clinical study of edoxaban

Thrombosis Journal

Research

Kenji Abe¹  Tetsuya Kimura²  Kei Ibusuki²  Mashio Nakamura³  Takeshi Fuji⁴  Shintaro Tachibana⁵  Satoru Fujita⁶ 

[1] Clinical Data and Biostatistics Department, Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, 140-8710, Tokyo, Japan;Daiichi Sankyo Co., Ltd., 3-5-1, Nihonbashi Honcho, Chuo-ku, 103-8426, Tokyo, Japan;Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, 514-8507, Tsu, Mie, Japan;Department of Orthopedic Surgery, Japan Community Healthcare Organization Osaka Hospital, 4-2-78 Fukushima, 553-0003, Fukushima-ku, Osaka, Japan;Department of Orthopedic Surgery, Mishuku Hospital, 5-33-12 Shimomeguro, Meguro-ku, 153-0051, Tokyo, Japan;Department of Orthopedic Surgery, Takarazuka Daiichi Hospital, 19-5 Kogetsu-cho, 665-0832, Takarazuka, Japan;

关键词: Venous thromboembolism;    Deep vein thrombosis;    Intermittent pneumatic compression;    Graduated compression stockings;    Edoxaban;    Enoxaparin;    Total knee arthroplasty;    Orthopedic surgery;    VTE;    DVT;   

DOI  :  10.1186/s12959-016-0087-z

 received in 2015-12-08, accepted in 2016-05-25,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundGuidelines from the Japanese Circulation Society recommend prophylaxis with anticoagulation plus intermittent pneumatic compression or graduated compression stockings (GCS) among patients at the highest risk for developing venous thromboembolism (VTE). However, the benefits of concomitant GCS use for patients undergoing total knee arthroplasty (TKA) and receiving anticoagulation remain unknown. In this study, the efficacy of GCS plus anticoagulation compared with anticoagulation alone was evaluated among patients undergoing TKA.MethodsThis study is a post hoc analysis of a previously reported phase 3 trial involving patients undergoing TKA. In the primary study, which permitted the use of GCS for mechanical prophylaxis, patients were randomized to receive edoxaban 30 mg once daily or enoxaparin 20 mg twice daily for 11 to 14 days following TKA. The primary endpoint was the incidence of VTE, a composite of symptomatic deep vein thrombosis (DVT), symptomatic pulmonary embolism (PE), and asymptomatic DVT. Treatment comparisons were performed using the chi-square test, and the 95 % confidence intervals were calculated.ResultsAmong patients receiving edoxaban, the incidence of VTE was 3.8 and 5.8 % for patients with and without GCS, respectively. For patients receiving enoxaparin, VTE incidence was 8.4 and 20.8 % among those with and without GCS, respectively. Overall, VTE incidence was 6.0 and 13.0 % for anticoagulated patients with and without GCS mechanical prophylaxis, respectively. No deaths or symptomatic PE were reported during this study.ConclusionsAlthough the incidence of VTE was >2-fold lower among patients receiving anticoagulation plus GCS compared with those receiving anticoagulation alone, statistical significance was not achieved. Further studies are required to confirm the findings of this preliminary analysis.Trial registrationClinicalTrials.gov Identifier: NCT01181102

【 授权许可】

CC BY   
© Fuji et al. 2016